Genetic Testing in Sleep Disorders

Diagnostic Approach

The American Academy of Sleep Medicine recommends that genetic testing is not part of the standard diagnostic workup for common sleep disorders like obstructive sleep apnea, narcolepsy, or restless legs syndrome 1, 2, 3.
Diagnosis of these conditions relies on clinical evaluation, questionnaires, polysomnography, and Multiple Sleep Latency Tests rather than genetic panels 1, 2, 3, 4, 5.
The National Comprehensive Cancer Network suggests that clinical history and symptom assessment, screening questionnaires, and objective testing are prioritized in the diagnostic pathway 2, 3, 4, 5.
The American College of Cardiology notes that in progressive cardiac conduction disease with bradycardia during sleep, genetic testing may be considered when there is isolated conduction disease or concomitant congenital heart disease, especially with positive family history 9.

For narcolepsy, diagnosis is made through clinical criteria combined with polysomnography and Multiple Sleep Latency Tests showing sleep-onset REM periods 4, 5, 3.
For obstructive sleep apnea, no genetic panel is recommended or available for routine clinical diagnosis, and diagnosis relies on clinical suspicion, screening questionnaires, and confirmatory sleep studies 1, 4, 5.
For restless legs syndrome, diagnosis is clinical, based on uncomfortable sensations and urge to move legs that worsen at night, and the only genetic-related testing recommended is checking ferritin levels 4, 5, 2.

Genetic testing is diagnostic for Prader-Willi syndrome, which involves loss of expression of paternal chromosome 15q11.2-q13, particularly the SNORD116 region 6, 7, 8.
Prader-Willi syndrome patients have multiple sleep disorders, including central sleep apnea, obstructive sleep apnea, excessive daytime sleepiness, narcolepsy-like phenotypes, and cataplexy 6, 7, 8.

Referral to a sleep specialist is recommended for comprehensive evaluation and management rather than pursuing genetic testing 4, 5, 2, 3.